Effects of COVID-19 on preclinical and clinical research in neurology: Examples from research on neurodegeneration and Alzheimer's disease

B. Joy Snider; David M. Holtzman

doi:10.1016/j.neuron.2021.08.026

Effects of COVID-19 on preclinical and clinical research in neurology: Examples from research on neurodegeneration and Alzheimer's disease

B. Joy Snider, David M. Holtzman

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

The COVID-19 pandemic has had a profound impact on neuroscientists, including those involved in translational research. In this NeuroView, we discuss the positive and negative effects of the pandemic on preclinical research and clinical studies in humans.

Original language	English
Pages (from-to)	3199-3202
Number of pages	4
Journal	Neuron
Volume	109
Issue number	20
DOIs	https://doi.org/10.1016/j.neuron.2021.08.026
State	Published - Oct 20 2021

Keywords

Alzheimer's disease
COVID-19
clinical trials
translational neuroscience

Access to Document

10.1016/j.neuron.2021.08.026

Cite this

@article{70b1689c63984c5f9385a54f931b9e3b,

title = "Effects of COVID-19 on preclinical and clinical research in neurology: Examples from research on neurodegeneration and Alzheimer's disease",

abstract = "The COVID-19 pandemic has had a profound impact on neuroscientists, including those involved in translational research. In this NeuroView, we discuss the positive and negative effects of the pandemic on preclinical research and clinical studies in humans.",

keywords = "Alzheimer's disease, COVID-19, clinical trials, translational neuroscience",

author = "Snider, {B. Joy} and Holtzman, {David M.}",

note = "Publisher Copyright: {\textcopyright} 2021 Elsevier Inc.",

year = "2021",

month = oct,

day = "20",

doi = "10.1016/j.neuron.2021.08.026",

language = "English",

volume = "109",

pages = "3199--3202",

journal = "Neuron",

issn = "0896-6273",

number = "20",

}

TY - JOUR

T1 - Effects of COVID-19 on preclinical and clinical research in neurology

T2 - Examples from research on neurodegeneration and Alzheimer's disease

AU - Snider, B. Joy

AU - Holtzman, David M.

PY - 2021/10/20

Y1 - 2021/10/20

N2 - The COVID-19 pandemic has had a profound impact on neuroscientists, including those involved in translational research. In this NeuroView, we discuss the positive and negative effects of the pandemic on preclinical research and clinical studies in humans.

AB - The COVID-19 pandemic has had a profound impact on neuroscientists, including those involved in translational research. In this NeuroView, we discuss the positive and negative effects of the pandemic on preclinical research and clinical studies in humans.

KW - Alzheimer's disease

KW - COVID-19

KW - clinical trials

KW - translational neuroscience

UR - http://www.scopus.com/inward/record.url?scp=85120526522&partnerID=8YFLogxK

U2 - 10.1016/j.neuron.2021.08.026

DO - 10.1016/j.neuron.2021.08.026

M3 - Article

C2 - 34525328

AN - SCOPUS:85120526522

SN - 0896-6273

VL - 109

SP - 3199

EP - 3202

JO - Neuron

JF - Neuron

IS - 20

ER -

Effects of COVID-19 on preclinical and clinical research in neurology: Examples from research on neurodegeneration and Alzheimer's disease

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this